These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

965 related articles for article (PubMed ID: 9525605)

  • 1. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.
    Platt EJ; Wehrly K; Kuhmann SE; Chesebro B; Kabat D
    J Virol; 1998 Apr; 72(4):2855-64. PubMed ID: 9525605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
    Lee S; Lapham CK; Chen H; King L; Manischewitz J; Romantseva T; Mostowski H; Stantchev TS; Broder CC; Golding H
    J Virol; 2000 Jun; 74(11):5016-23. PubMed ID: 10799575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in the CCR5 genes of African green monkeys and mice implicate specific amino acids in infections by simian and human immunodeficiency viruses.
    Kuhmann SE; Platt EJ; Kozak SL; Kabat D
    J Virol; 1997 Nov; 71(11):8642-56. PubMed ID: 9343222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1.
    Kozak SL; Platt EJ; Madani N; Ferro FE; Peden K; Kabat D
    J Virol; 1997 Feb; 71(2):873-82. PubMed ID: 8995603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses.
    Bannert N; Schenten D; Craig S; Sodroski J
    J Virol; 2000 Dec; 74(23):10984-93. PubMed ID: 11069993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive mutations in the V3 loop of gp120 enhance fusogenicity of human immunodeficiency virus type 1 and enable use of a CCR5 coreceptor that lacks the amino-terminal sulfated region.
    Platt EJ; Kuhmann SE; Rose PP; Kabat D
    J Virol; 2001 Dec; 75(24):12266-78. PubMed ID: 11711617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1.
    Kuhmann SE; Platt EJ; Kozak SL; Kabat D
    J Virol; 2000 Aug; 74(15):7005-15. PubMed ID: 10888639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation.
    Rana S; Besson G; Cook DG; Rucker J; Smyth RJ; Yi Y; Turner JD; Guo HH; Du JG; Peiper SC; Lavi E; Samson M; Libert F; Liesnard C; Vassart G; Doms RW; Parmentier M; Collman RG
    J Virol; 1997 Apr; 71(4):3219-27. PubMed ID: 9060685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and use of human immunodeficiency virus type 1 coreceptors by human alveolar macrophages.
    Worgall S; Connor R; Kaner RJ; Fenamore E; Sheridan K; Singh R; Crystal RG
    J Virol; 1999 Jul; 73(7):5865-74. PubMed ID: 10364338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine receptor-usage of clinical HIV-1 isolates obtained from patients with HIV-1 infection in late clinical stages using PHA-blast.
    Matsuda S; Miyata M
    Microbiol Immunol; 1999; 43(10):967-74. PubMed ID: 10585143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1.
    Kabat D; Kozak SL; Wehrly K; Chesebro B
    J Virol; 1994 Apr; 68(4):2570-7. PubMed ID: 8139036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry.
    Simmons G; Wilkinson D; Reeves JD; Dittmar MT; Beddows S; Weber J; Carnegie G; Desselberger U; Gray PW; Weiss RA; Clapham PR
    J Virol; 1996 Dec; 70(12):8355-60. PubMed ID: 8970955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains.
    Huang L; Bosch I; Hofmann W; Sodroski J; Pardee AB
    J Virol; 1998 Nov; 72(11):8952-60. PubMed ID: 9765440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor.
    Hill CM; Deng H; Unutmaz D; Kewalramani VN; Bastiani L; Gorny MK; Zolla-Pazner S; Littman DR
    J Virol; 1997 Sep; 71(9):6296-304. PubMed ID: 9261346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies.
    Ly A; Stamatatos L
    J Virol; 2000 Aug; 74(15):6769-76. PubMed ID: 10888615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G protein-dependent CCR5 signaling is not required for efficient infection of primary T lymphocytes and macrophages by R5 human immunodeficiency virus type 1 isolates.
    Amara A; Vidy A; Boulla G; Mollier K; Garcia-Perez J; Alcamí J; Blanpain C; Parmentier M; Virelizier JL; Charneau P; Arenzana-Seisdedos F
    J Virol; 2003 Feb; 77(4):2550-8. PubMed ID: 12551993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR6-Mediated Simian Immunodeficiency Virus SIVagmSab Entry into Sabaeus African Green Monkey Lymphocytes Implicates Widespread Use of Non-CCR5 Pathways in Natural Host Infections.
    Wetzel KS; Yi Y; Elliott STC; Romero D; Jacquelin B; Hahn BH; Muller-Trutwin M; Apetrei C; Pandrea I; Collman RG
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabbit cells expressing human CD4 and human CCR5 are highly permissive for human immunodeficiency virus type 1 infection.
    Speck RF; Penn ML; Wimmer J; Esser U; Hague BF; Kindt TJ; Atchison RE; Goldsmith MA
    J Virol; 1998 Jul; 72(7):5728-34. PubMed ID: 9621031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of CD4 and CCR5 levels in the susceptibility of primary macrophages to infection by CCR5-dependent HIV type 1 isolates.
    Pesenti E; Pastore C; Lillo F; Siccardi AG; Vercelli D; Lopalco L
    AIDS Res Hum Retroviruses; 1999 Jul; 15(11):983-7. PubMed ID: 10445810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.